Design, Synthesis and In Vitro Evaluation of Piperazine Incorporated Novel Anticancer Agents

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/13288

Full metadata record

DC Field	Value	Language
dc.contributor.author	Jadhav, Hemant R.	-
dc.date.accessioned	2023-11-30T10:32:33Z	-
dc.date.available	2023-11-30T10:32:33Z	-
dc.date.issued	2018	-
dc.identifier.uri	https://benthamscience.com/article/87338	-
dc.identifier.uri	http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13288	-
dc.description.abstract	Novel 4-(3-(4-ethylpiperazin-1-yl)propoxy)-N-phenylbenzamide derivatives (C-1 to C-10) and (4-(3-(4-ethylpiperazin-1-yl)propoxy)phenyl)(4-(2-methoxyphenyl)piperazin-1- yl)ethanone derivatives (C-11 to C-16) were designed and synthesized by pharmacophore approach.	en_US
dc.language.iso	en	en_US
dc.publisher	Bentham Science	en_US
dc.subject	Pharmacy	en_US
dc.subject	Carcinoma	en_US
dc.subject	Cytotoxocity	en_US
dc.subject	Epidermal growth factor receptor inhibitors	en_US
dc.subject	Ethyl piperazine	en_US
dc.subject	Cancer line	en_US
dc.title	Design, Synthesis and In Vitro Evaluation of Piperazine Incorporated Novel Anticancer Agents	en_US
dc.type	Article	en_US
Appears in Collections:	Department of Pharmacy

Files in This Item:

There are no files associated with this item.